However, if (despite the best efforts of AMPK) tumours nevertheless did become established due to activating mutations in proto-oncogenes or loss-of-function mutations in other tumour suppressors, then AMPK may simply switch to become a tumour promoter instead (Figure 9). This evidence concerns the gene PRKAB1 and neoplasm.